Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes.
about
Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Update on the ROADMAP clinical ...... evelopment in type 2 diabetes.
@en
type
label
Update on the ROADMAP clinical ...... evelopment in type 2 diabetes.
@en
prefLabel
Update on the ROADMAP clinical ...... evelopment in type 2 diabetes.
@en
P2860
P356
P1476
Update on the ROADMAP clinical ...... evelopment in type 2 diabetes.
@en
P2093
Christos Chatzikyrkou
P2860
P304
P356
10.1586/ERC.12.100
P577
2012-09-01T00:00:00Z